美迪西股价跌5.15%，富国基金旗下1只基金重仓，持有400股浮亏损失1156元

Group 1 - The core point of the news is that Meidi Xi's stock price dropped by 5.15% to 53.26 CNY per share, with a trading volume of 167 million CNY and a turnover rate of 2.30%, resulting in a total market capitalization of 7.156 billion CNY [1] - Meidi Xi, established on February 2, 2004, and listed on November 5, 2019, is located in the Pudong New Area of Shanghai and specializes in providing comprehensive new drug research and development services for pharmaceutical companies and other new drug research institutions [1] - The company's main business revenue composition includes 50.34% from preclinical research, 49.64% from drug discovery and pharmaceutical research, and 0.01% from other supplementary services [1] Group 2 - According to data from the top ten holdings of funds, one fund under the Fortune Fund has a significant position in Meidi Xi, specifically the Fortune SSE Index ETF Link A/B (100053), which held 400 shares in the third quarter, unchanged from the previous period, ranking as the seventh largest holding [2] - The Fortune SSE Index ETF Link A/B (100053) was established on January 30, 2011, with a latest scale of 280 million CNY, and has achieved a year-to-date return of 17.77%, ranking 2823 out of 4206 in its category [2] - The fund has a one-year return of 18.79%, ranking 2537 out of 4012, and a cumulative return of 90.9% since its inception [2] Group 3 - The fund managers of the Fortune SSE Index ETF Link A/B (100053) are Wang Baohe and Fang Min, with Wang having a cumulative tenure of 14 years and 279 days, managing a total fund size of 10.562 billion CNY, achieving a best fund return of 101.71% during his tenure [3] - Fang Min has a cumulative tenure of 11 years and 17 days, managing a total fund size of 24.704 billion CNY, with a best fund return of 209.34% during his tenure [3]